Establishment of highly differentiated immortalized human hepatocyte line with simian virus 40 large tumor antigen for liver based cell therapy

ASAIO Journal

Volumn 51, Issue 3, 2005, Pages 262-268

  Li, Jun ^a   Li, Lan Juan ^a   Cao, Hong Cui ^a   Sheng, Guo Ping ^a   Yu, Hai Ying ^a   Xu, Wei ^a   Sheng, Ji Fang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL ORGANS; BIOLOGICAL ORGANS; CELL CULTURE; CELLS; ENZYMES; GENES; IMMUNOLOGY; METABOLISM; TRANSPLANTATION (SURGICAL); CODES (STANDARDS); COMPUTER NETWORKS; COMPUTER SIMULATION;

BIOARTIFICIAL LIVER SUPPORT SYSTEM; HEPATOCYTES; LIVER; LIVER FAILURE;

CELL IMMOBILIZATION; SECURITY OF DATA;

ALBUMIN; BIOLOGICAL MARKER; GLYCOGEN; UREA; VIRUS LARGE T ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ADULT; ANIMAL EXPERIMENT; ARTICLE; BIOARTIFICIAL LIVER; BIOARTIFICIAL ORGAN; CARCINOGENICITY; CELL DIFFERENTIATION; CELL LINE; CELL TRANSPLANTATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CULTURE; LIVER PARENCHYMA; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; SIMIAN VIRUS 40; UREA CYCLE;

ALBUMINS; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELLS, CULTURED; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, SCID; RNA, MESSENGER; SIMIAN VIRUS 40; UREA;

MALNETS; NETWORK INTRUDERS;

EID: 18744401640     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000161045.16805.8B     Document Type: Article

References (35)

1. Sass DA, Shakil AO: Fulminant hepatic failure. Gastroenterol Clin North Am 32: 1195-1211, 2003.
2. Krasko A, Deshpande K, Bonvino S: Liver failure, transplantation, and critical care. Crit Care Clin 19: 155-183, 2003.
3. Tanaka M, Watanabe S, Masaki T, et al: Fulminant hepatic failure caused by malignant melanoma of unknown primary origin. J Gastroenterol 39: 804-806, 2004.
4. Montalti R, Nardo B, Bertelli R, et al: Donor pool expansion in liver transplantation. Liver Transpl 9: 254-259, 2003.
5. Rudow DL, Russo MW, Hafliger S, Emond JC, Brown RS Jr: Clinical and ethnic differences in candidates listed for liver transplantation with and without potential living donors. Transplant Proc 36: 520-522, 2004.
6. Wu J, Zheng SS: Liver transplantation in China: Problems and their solutions. Hepatobiliary Pancreat Dis Int 3: 170-174, 2004.
7. Lee SW, Wang X, Chowdhury NR, Roy-Chowdhury J: Hepatocyte transplantation: State of the art and strategies for overcoming existing hurdles. Ann Hepatol 3: 48-53, 2004.
8. Min AD, Theise ND: Prospects for cell-based therapies for liver disease. Panminerva Med 46: 43-48, 2004.
9. Di Campli C, Nestola M, Piscaglia AC, et al: Cell-based therapy for liver diseases. Eur Rev Med Pharmacol Sci 7: 41-44, 2003.
10. Barbich M, Lorenti A, Hidalgo A, et al: Culture and characterization of human hepatocytes obtained after graft reduction for liver transplantation: A reliable source of cells for a bioartificial liver. Artif Organs 28: 676-682, 2004.
11. Fox IJ, Roy-Chowdhury J: Hepatocyte transplantation. J Hepatol 40: 878-886, 2004.
12. Oertel M, Rosencrantz R, Chen YQ, et al: Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors. Hepatology 37: 994-1005, 2003.
13. Kobayashi N, Fujiwara T, Westerman KA, et al: Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 287: 1258-1262, 2000.
14. Kobayashi N, Miyazaki M, Fukaya K, et al: Establishment of a highly differentiated immortalized human hepatocyte cell line as a source of hepatic function in the bioartificial liver. Transplant Proc 32: 237-241, 2000.
15. Kobayashi N, Noguchi H, Fujiwara T, Westerman KA, Leboulch P, Tanaka N: Establishment of a highly differentiated immortalized adult human hepatocyte cell line by retroviral gene transfer. Transplant Proc 32: 2368-2369, 2000.
16. Andres D, Diez-Fernandez C, Zaragoza A, Alvarez A, Cascales M: Induction of cell proliferation by cyclosporine A in primary cultures of rat hepatocytes. Biochem Pharmacol 61: 427-435, 2001.
17. Katsura N, Ikai I, Mitaka T, et al: Long-term culture of primary human hepatocytes with preservation of proliferative capacity and differentiated functions. J Surg Res 106: 115-123, 2002.
18. Lazaro CA, Croager EJ, Mitchell C, et al: Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. Hepatology 38: 1095-1106, 2003.
19. Cai J, Ito M, Westerman KA, Kobayashi N, Leboulch P, Fox IJ: Construction of a non-tumorigenic rat hepatocyte cell line for transplantation: Reversal of hepatocyte immortalization by site-specific excision of the SV40 T antigen. J Hepatol 33: 701-708, 2000.
20. Yin C, Mien Chia S, Hoon Quek C, et al: Microcapsules with improved mechanical stability for hepatocyte culture. Biomaterials 24: 1771-1780, 2003.
21. Parent R, Marion MJ, Furio L, Trepo C, Petit MA: Origin and characterization of a human bipotent liver progenitor cell line. Gastroenterology 126: 1147-1156, 2004.
22. Malhi H, Irani AN, Gagandeep S, Gupta S: Isolation of human progenitor liver epithelial cells with extensive replication capacity and differentiation into mature hepatocytes. J Cell Sci 115: 2679-2688, 2002.
23. Kudriavtseva MV, Sakuta GA, Skorina AD, Shtein GI, Emel'ianov AV, Kudriavtsev BN: A quantitative evaluation of the glycogen content of the hepatocytes from different lobular ares of the normal human liver and in chronic hepatitides of different etiologies. Tsitologiia 37: 70-480, 1954.
24. Yamamoto H, Quinn G, Asari A, et al: Differentiation of embryonic stem cells into hepatocytes: Biological functions and therapeutic application. Hepatology 37: 983-993, 2003.
25. Santori G, Cottalasso D, Antonucci A, et al: Orthotopic liver transplantation in a young adult (33 years old) using an 84-year-old donor. Hepatogastroenterology 48: 1138-1141, 2001.
26. Frilling A, Malago M, Broelsch CE: Current status of liver transplantation for treatment of hepatocellular carcinoma. Dig Dis 19: 333-337, 2001.
27. Takegoshi K, Tanaka K, Nomura H, Miyagi K, Taira S, Takayanagi N: Successful living donor liver transplantation for polycystic liver in a patient with autosomal-dominant polycystic kidney disease. J Clin Gastroenterol 33: 229-231, 2001.
28. Selden C, Hodgson H: Cellular therapies for liver replacement. Transpl Immunol 12: 273-288, 2004.
29. Allen JW, Hassanein T, Bhatia SN: Advances in bioartificial liver devices. Hepatology 34: 447-455, 2001.
30. Kuddus R, Patzer JF, Lopez R, et al: Valuation of transmission of porcine endogenous retrovirus into patients subjected to hemoperfusion using an extracorporeal bioartificial liver support system. Transplant Proc 33: 1976, 2001.
31. Jalan R, Williams R: Bio-artificial liver support for acute liver failure: Should we be using it to treat patients? Transplantation 73: 165-166, 2002.
32. Malhi H, Gupta S: Hepatocyte transplantation: New horizons and challenges. J Hepatobiliary Pancreat Surg 8: 40-50, 2001.
33. Liu J, Jauregui HO, Faris RA, et al: Growth and metabolic activity of immortalized porcine hepatocytes in extracorporeal hollow-fiber liver assist devices. Artif Organs 25: 539-545, 2001.
34. Kim BH, Sung SR, Park JK, et al: Survival of conditionally immortalized hepatocytes in the spleen of syngeneic rats. J Gastroenterol Hepatol 16: 52-60, 2001.
35. Jun Li, Lan-Juan Li, Guo-Ping Sheng: Establishment of immortalized human hepatocyte line for cell transplantation [Chinese]. J Infect Dis 2: 155-158, 2004.